Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic Aneurysm

Background The proteome is a key source of therapeutic targets. We conducted a comprehensive Mendelian randomization analysis across the proteome to identify potential protein markers and therapeutic targets for abdominal aortic aneurysm (AAA). Methods and Results Our study used plasma proteomics da...

Full description

Saved in:
Bibliographic Details
Main Authors: Ka Zhang, Yuan Liu, Aiqin Mao, Changzhu Li, Li Geng, Hao Kan
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.038193
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540967918370816
author Ka Zhang
Yuan Liu
Aiqin Mao
Changzhu Li
Li Geng
Hao Kan
author_facet Ka Zhang
Yuan Liu
Aiqin Mao
Changzhu Li
Li Geng
Hao Kan
author_sort Ka Zhang
collection DOAJ
description Background The proteome is a key source of therapeutic targets. We conducted a comprehensive Mendelian randomization analysis across the proteome to identify potential protein markers and therapeutic targets for abdominal aortic aneurysm (AAA). Methods and Results Our study used plasma proteomics data from the UK Biobank, comprising 2923 proteins from 54 219 individuals, and from deCODE Genetics, which measured 4907 proteins across 35 559 individuals. Significant proteomic quantitative trait loci were used as instruments for Mendelian randomization. Genetic associations with AAA were sourced from the AAAgen consortium, a large‐scale genome‐wide association study meta‐analysis involving 37 214 cases and 1 086 107 controls, and the FinnGen study, which included 3869 cases and 381 977 controls. Sequential analyses of colocalization and summary‐data‐based Mendelian randomization were performed to verify the causal roles of candidate proteins. Additionally, single‐cell expression analysis, protein–protein interaction network analysis, pathway enrichment analysis, and druggability assessments were conducted to identify cell types with enriched expression and prioritize potential therapeutic targets. The proteome‐wide Mendelian randomization analysis identified 34 proteins associated with AAA risk. Among them, 2 proteins, COL6A3 and PRKD2, were highlighted by colocalization analysis, summary‐data‐based Mendelian randomization, and the heterogeneity in an independent instrument test, providing the most convincing evidence. These protein‐coding genes are primarily expressed in macrophages, smooth muscle cells, and mast cells within abdominal aortic aneurysm tissue. Several causal proteins are involved in pathways regulating lipid metabolism, immune responses, and extracellular matrix organization. Nine proteins have already been targeted for drug development in diabetes and other cardiovascular diseases, presenting opportunities for repurposing as AAA therapeutic targets. Conclusions This study identifies causal proteins for AAA, enhancing our understanding of its molecular cause and advancing the development of therapeutics.
format Article
id doaj-art-b36b11182a2f48e9803e88f16ae09e9f
institution Kabale University
issn 2047-9980
language English
publishDate 2025-02-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-b36b11182a2f48e9803e88f16ae09e9f2025-02-04T11:00:01ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802025-02-0114310.1161/JAHA.124.038193Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic AneurysmKa Zhang0Yuan Liu1Aiqin Mao2Changzhu Li3Li Geng4Hao Kan5Wuxi School of Medicine Jiangnan University Wuxi Jiangsu ChinaWuxi School of Medicine Jiangnan University Wuxi Jiangsu ChinaWuxi School of Medicine Jiangnan University Wuxi Jiangsu ChinaWuxi School of Medicine Jiangnan University Wuxi Jiangsu ChinaWuxi School of Medicine Jiangnan University Wuxi Jiangsu ChinaWuxi School of Medicine Jiangnan University Wuxi Jiangsu ChinaBackground The proteome is a key source of therapeutic targets. We conducted a comprehensive Mendelian randomization analysis across the proteome to identify potential protein markers and therapeutic targets for abdominal aortic aneurysm (AAA). Methods and Results Our study used plasma proteomics data from the UK Biobank, comprising 2923 proteins from 54 219 individuals, and from deCODE Genetics, which measured 4907 proteins across 35 559 individuals. Significant proteomic quantitative trait loci were used as instruments for Mendelian randomization. Genetic associations with AAA were sourced from the AAAgen consortium, a large‐scale genome‐wide association study meta‐analysis involving 37 214 cases and 1 086 107 controls, and the FinnGen study, which included 3869 cases and 381 977 controls. Sequential analyses of colocalization and summary‐data‐based Mendelian randomization were performed to verify the causal roles of candidate proteins. Additionally, single‐cell expression analysis, protein–protein interaction network analysis, pathway enrichment analysis, and druggability assessments were conducted to identify cell types with enriched expression and prioritize potential therapeutic targets. The proteome‐wide Mendelian randomization analysis identified 34 proteins associated with AAA risk. Among them, 2 proteins, COL6A3 and PRKD2, were highlighted by colocalization analysis, summary‐data‐based Mendelian randomization, and the heterogeneity in an independent instrument test, providing the most convincing evidence. These protein‐coding genes are primarily expressed in macrophages, smooth muscle cells, and mast cells within abdominal aortic aneurysm tissue. Several causal proteins are involved in pathways regulating lipid metabolism, immune responses, and extracellular matrix organization. Nine proteins have already been targeted for drug development in diabetes and other cardiovascular diseases, presenting opportunities for repurposing as AAA therapeutic targets. Conclusions This study identifies causal proteins for AAA, enhancing our understanding of its molecular cause and advancing the development of therapeutics.https://www.ahajournals.org/doi/10.1161/JAHA.124.038193abdominal aortic aneurysmbiomarkerdrug targetplasma proteinproteome‐wide Mendelian randomization
spellingShingle Ka Zhang
Yuan Liu
Aiqin Mao
Changzhu Li
Li Geng
Hao Kan
Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic Aneurysm
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
abdominal aortic aneurysm
biomarker
drug target
plasma protein
proteome‐wide Mendelian randomization
title Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic Aneurysm
title_full Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic Aneurysm
title_fullStr Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic Aneurysm
title_full_unstemmed Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic Aneurysm
title_short Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic Aneurysm
title_sort proteome wide mendelian randomization identifies therapeutic targets for abdominal aortic aneurysm
topic abdominal aortic aneurysm
biomarker
drug target
plasma protein
proteome‐wide Mendelian randomization
url https://www.ahajournals.org/doi/10.1161/JAHA.124.038193
work_keys_str_mv AT kazhang proteomewidemendelianrandomizationidentifiestherapeutictargetsforabdominalaorticaneurysm
AT yuanliu proteomewidemendelianrandomizationidentifiestherapeutictargetsforabdominalaorticaneurysm
AT aiqinmao proteomewidemendelianrandomizationidentifiestherapeutictargetsforabdominalaorticaneurysm
AT changzhuli proteomewidemendelianrandomizationidentifiestherapeutictargetsforabdominalaorticaneurysm
AT ligeng proteomewidemendelianrandomizationidentifiestherapeutictargetsforabdominalaorticaneurysm
AT haokan proteomewidemendelianrandomizationidentifiestherapeutictargetsforabdominalaorticaneurysm